Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 237

Results For "development"

2761 News Found

North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


Over one lakh SARS-CoV-2 genomes sequenced till November
Policy | December 03, 2021

Over one lakh SARS-CoV-2 genomes sequenced till November

Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry


Yokogawa develops Single Cellome System SS2000 for subcelluar sampling
Medical Device | December 02, 2021

Yokogawa develops Single Cellome System SS2000 for subcelluar sampling

A single-cell analysis solution that revolutionizes efficiency in drug discovery research by automating the collection of specific cells and intracellular components


Sanofi to acquire Origimm Biotechnology to treat acne with vaccine
News | December 02, 2021

Sanofi to acquire Origimm Biotechnology to treat acne with vaccine

Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide


Lupin partners with TTP for soft-mist inhalation tech platform
Biotech | December 02, 2021

Lupin partners with TTP for soft-mist inhalation tech platform

Soft-mist inhalation (SMI) technology allows for delivery of inhalation drugs from a small, portable hand-held inhaler device without the use of propellants


LifeCell Diagnostics introduces the NovaSeq 6000
Medical Device | December 02, 2021

LifeCell Diagnostics introduces the NovaSeq 6000

One of the very few facilities in India to have this capability, marking a remarkable feat in LifeCell’s expedition to take genome sequencing to the next level in India


Roche completes acquisition of TIB Molbiol
Medical Device | December 01, 2021

Roche completes acquisition of TIB Molbiol

TIB Molbiol excels in ultra-rapid assay development for emerging infectious diseases, strongly demonstrated during the Covid-19 pandemic


U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib
Biotech | November 30, 2021

U.S. FDA accepts Bristol Myers Squibb’s application for Deucravacitinib

Applications supported by positive results from the pivotal Phase 3 POETYK-PSO clinical trial program demonstrating superior efficacy of deucravacitinib over Otezla (apremilast)


Conference highlights opportunities in the nursing profession
News | November 30, 2021

Conference highlights opportunities in the nursing profession

This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year


Thermo Fisher Scientific’s new CRISPR Genome editing protein
Biotech | November 30, 2021

Thermo Fisher Scientific’s new CRISPR Genome editing protein

Growing CRISPR genome editing portfolio supports researchers on path to future therapeutic applications